ELEVAI Labs Inc
NASDAQ:ELAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ELEVAI Labs Inc
Pre-Tax Income
ELEVAI Labs Inc
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
Pre-Tax Income
-$4.3m
|
CAGR 3-Years
-221%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kenvue Inc
NYSE:KVUE
|
Pre-Tax Income
$2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Safety Shot Inc
NASDAQ:SHOT
|
Pre-Tax Income
-$48.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-120%
|
CAGR 10-Years
N/A
|
|
|
Horizon Kinetics Holding Corp
OTC:HKHC
|
Pre-Tax Income
$899.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
83%
|
|
|
Bonk Inc
NASDAQ:BNKK
|
Pre-Tax Income
-$68.2m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
F
|
Functional Brands Inc
NASDAQ:MEHA
|
Pre-Tax Income
$758.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ELEVAI Labs Inc
Glance View
ELEVAI Labs Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Newport Beach, California. The company went IPO on 2023-11-21. Elevai Labs, Inc. is a physician-dispensed skincare company. The firm conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. The company produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare products. The company has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.
See Also
What is ELEVAI Labs Inc's Pre-Tax Income?
Pre-Tax Income
-4.3m
USD
Based on the financial report for Dec 31, 2023, ELEVAI Labs Inc's Pre-Tax Income amounts to -4.3m USD.
What is ELEVAI Labs Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
-221%
Over the last year, the Pre-Tax Income growth was -139%. The average annual Pre-Tax Income growth rates for ELEVAI Labs Inc have been -221% over the past three years .
